Tracheobronchomalacia: Treatment Outcomes

NCT00550602 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2017-02-03

No results posted yet for this study

Summary

The purpose of this study is to evaluate respiratory symptoms and their impact in the quality of life and after treatment of the respiratory condition (tracheobronchomalacia - TBM).

Conditions

  • Tracheomalacia
  • Tracheobronchomalacia

Sponsors & Collaborators

Principal Investigators

  • Armin Ernst, M.D. FCCP · Beth Israel Deaconess Medical Center

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-01-31
Primary Completion
2010-03-31
Completion
2010-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00550602 on ClinicalTrials.gov